Cargando…
Sildenafil Improves Pulmonary Vascular Remodeling in a Rat Model of Persistent Pulmonary Hypertension of the Newborn
Persistent pulmonary hypertension of the newborn (PPHN) is characterized by pulmonary arterial remodeling mainly because of apoptosis resistance and excessive proliferation of pulmonary artery smooth muscle cells (PASMCs). Sildenafil is a phosphodiesterase-5 inhibitor. Some reports have shown that s...
Autores principales: | Kang, Lili, Liu, Xianghong, Li, Zilong, Li, XiaoMei, Han, Yujie, Liu, Chen, Zhao, Cuifen, Li, Xiaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988230/ https://www.ncbi.nlm.nih.gov/pubmed/36198097 http://dx.doi.org/10.1097/FJC.0000000000001373 |
Ejemplares similares
-
Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)
por: Vijay Kumar, J.R., et al.
Publicado: (2021) -
Black lung persistent pulmonary hypertension of the newborn: Saudi experience with sildenafil and nitric oxide
por: Alnemri, AbdulRahman M.
Publicado: (2017) -
Is Sildenafil an Effective Therapy in the Management of Persistent Pulmonary Hypertension?
por: Yaseen, Hakam, et al.
Publicado: (2012) -
Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
por: Wei, Enhuan, et al.
Publicado: (2023) -
Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report
por: Daniyan, Olapeju, et al.
Publicado: (2022)